
Sign up to save your podcasts
Or


Everyone is talking about “one-click AI,” but is it real or just a conference buzzword? In this episode of TriloTalk, Lisa Chamberlain James, Senior Partner at Trilogy, and Vladimir Penkrat, Associate VP Regulatory Affairs at Indegene, cut through the hype and explore what AI can actually do today in medical writing and regulatory affairs, where the biggest gaps are, and how organizations can actually make real progress.
By Trilogy Writing & Consulting5
55 ratings
Everyone is talking about “one-click AI,” but is it real or just a conference buzzword? In this episode of TriloTalk, Lisa Chamberlain James, Senior Partner at Trilogy, and Vladimir Penkrat, Associate VP Regulatory Affairs at Indegene, cut through the hype and explore what AI can actually do today in medical writing and regulatory affairs, where the biggest gaps are, and how organizations can actually make real progress.